Advances in BRAF-targeted therapies for non-small cell lung cancer: the promise of encorafenib and binimetinib

被引:1
作者
Fareed, Areeba [1 ]
Amir, Nabiha [1 ]
Ajaz, Humna [2 ]
Sohail, Afra [1 ]
Vaid, Rayyan [1 ]
Farhat, Solay [3 ]
机构
[1] Karachi Med & Dent Coll, Dept Med, Karachi, Pakistan
[2] Jinnah Sindh Med Univ, Karachi, Pakistan
[3] Lebanese Univ, Fac Med Sci, Beirut, Lebanon
关键词
OPEN-LABEL; DABRAFENIB;
D O I
10.1097/JS9.0000000000001051
中图分类号
R61 [外科手术学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1891 / 1893
页数:3
相关论文
共 50 条
  • [31] The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer
    Melosky, Barbara
    Wheatley-Price, Paul
    Juergens, Rosalyn A.
    Sacher, Adrian
    Leighl, Natasha B.
    Tsao, Ming-Sound
    Cheema, Parneet
    Snow, Stephanie
    Liu, Geoffrey
    Card, Paul B.
    Chu, Quincy
    LUNG CANCER, 2021, 160 : 136 - 151
  • [32] Pathways and targeting avenues of BRAF in non-small cell lung cancer
    Imyanitov, Evgeny N.
    Mitiushkina, Natalia V.
    Kuligina, Ekatherina Sh.
    Tiurin, Vladislav I.
    Venina, Aigul R.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2024, 28 (07) : 613 - 622
  • [33] RAS and BRAF in the foreground for non-small cell lung cancer and colorectal cancer: Similarities and main differences for prognosis and therapies
    Giopanou, Ioanna
    Pintzas, Alexandros
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 146
  • [34] Advances in Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Targeted Therapy
    Giustini, Nicholas P.
    Jeong, Ah-Reum
    Buturla, James
    Bazhenova, Lyudmila
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 223 - +
  • [35] Targeted therapy in advanced non-small cell lung cancer: current advances and future trends
    Majeed, Umair
    Manochakian, Rami
    Zhao, Yujie
    Lou, Yanyan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [36] BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall
    Leonetti, Alessandro
    Facchinetti, Francesco
    Rossi, Giulio
    Minari, Roberta
    Conti, Antonia
    Friboulet, Luc
    Tiseo, Marcello
    Planchard, David
    CANCER TREATMENT REVIEWS, 2018, 66 : 82 - 94
  • [37] Immunotherapy Benefit in a Patient With Non-Small Cell Lung Cancer and a Rare BRAF Mutation
    Rittberg, Rebekah
    Banerji, Shantanu
    Green, Susan
    Qing, Gefei
    Dawe, David E.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
  • [38] Adding to the targeted therapy toolbox: BRAF and MEK inhibition in the treatment of BRAF V600E metastatic non-small cell lung cancer
    Myall, Nathaniel J.
    Wakelee, Heather A.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1233 - S1240
  • [39] New Targeted Therapy for Non-Small Cell Lung Cancer
    Chung, Eun Ki
    Yong, Seung Hyun
    Lee, Eun Hye
    Kim, Eun Young
    Chang, Yoon Soo
    Lee, Sang Hoon
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2023, 86 (01) : 1 - 13
  • [40] Advances in systemic therapy for non-small cell lung cancer
    Miller, Meagan
    Hanna, Nasser
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 375